The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Front-line daratumumab in newly diagnosed AL amyloidosis patients.
 
Vanessa Elaine Kennedy
No Relationships to Disclose
 
Nina Shah
Stock and Other Ownership Interests - Indapta Therapeutics
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech/Abbvie; Indapta Therapeutics; Karyopharm Therapeutics; Nektar; Nkarta; Oncopeptides; Precision Biosciences; Sanofi; Seagen; Surface Oncology; TeneoBio
Research Funding - Bluebird Bio; Celgene; Janssen; Sutter Medical Group
 
Jeffrey Lee Wolf
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Celgene; Janssen; TeneoBio
 
Thomas G. Martin
No Relationships to Disclose
 
Sandy Wai Kuan Wong
Consulting or Advisory Role - Amgen
Research Funding - Celgene; Fortis; Janssen; Roche